Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00131118
Status:
COMPLETED
Last Update Posted:
2017-06-01
First Post:
2005-08-15
Brief Title:
Zoledronic Acid in Children 1 -17 Years With Severe Osteogenesis Imperfecta
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Osteogenesis Imperfecta |
Keywords:
| Name | View |
|---|---|
| Osteogenesis Imperfecta Brittle bone disease bisphosphonate children | View |